All updates
All updates
today 207AI × 生物医药评分3737 AI × 生物医药评分5151 Generative modeling of intrinsically disordered protein regions by reinforcing sparse autoencoder features
AI × 生物医药评分4747 A Generalisation Signal Need Not Be a Model-Selection Signal
AI × 生物医药评分3232 R-GroundBench: A Diagnostic Benchmark for R-Group Groundingin Markush Molecular Editing
AI × 生物医药评分4444 OpenMTB-Audit: Exposing Over-Refusal and Clinical Expert Perspectives in LLM-Based Molecular Tumor Board Safety Evaluation
AI × 生物医药评分4747 Higher-Order Molecular Grammars for Generative and Foundation Models in Chemistry
AI × 生物医药评分3535 Does Learning Protein Folding Generalize to Broader Reasoning?
监管与产业动态评分1919 Antimicrobial resistance and social inequity: Why the one health approach must centre poverty
监管与产业动态评分2222 Adult vaccination coverage and missed preventive care opportunities among Filipino adults with diabetes: A cross-sectional study
监管与产业动态评分3131 Engineered nanovaccines for prophylactic and therapeutic immunotherapy against cancer and infectious disease
监管与产业动态精选评分5757 Spatial multi‑omics identifies an SPP1+ macrophage‑driven anti‑apoptotic niche in osteoarthritis synovium via the SPP1‑CD44 axis
监管与产业动态评分66 AI-Powered CMC Authoring: Keep Your Dossier in Sync - Fierce Pharma
监管与产业动态精选评分6767 RNA urine test outperforms standard bladder cancer tests and could help guide treatment
监管与产业动态精选评分3535 Abbott launches SimpleScreen CRC blood test in the US - Fierce Biotech
监管与产业动态精选评分4444 Researchers report early results from therapy designed for a single patient with a rare genetic form of ALS
监管与产业动态评分1111 Immunotherapy startup Adecto blames ‘risk-averse funding environment’ for closing down - Fierce Biotech
监管与产业动态评分3232 Novartis pens $7.8B deal for Abogen's in vivo autoimmune T-cell engager - Fierce Biotech
监管与产业动态评分1313 How to manage the side effects of radiation therapy
监管与产业动态评分2525 Colorectal cancer on the rise in adolescent patients, data analysis finds
监管与产业动态精选评分6060 Inflammation can reactivate 'sleeping' cancer cells hidden in the bone
监管与产业动态评分5252 Mass spectrometry offers faster look at the edges of brain tumors
监管与产业动态精选评分6868 An epigenetic blueprint reveals how aggressive MYC amplification fuels cancer
监管与产业动态精选评分3636 Generic, brand-name multiple sclerosis drugs may produce varied effects
监管与产业动态评分2424 Lab‑grown 'mini‑bladder' helps explain why urinary tract infections keep coming back
监管与产业动态精选评分5656 Hidden lymphatic signal amplifier could inform treatments for lymphedema and cancer metastasis
监管与产业动态评分1212 Chutes & Ladders—Bayer taps new chief medical officer; Cantor appointed PhRMA CEO - Fierce Biotech
监管与产业动态评分6666 Same-day chemotherapy boosts cancer vaccine responses in preclinical models
监管与产业动态评分3333 Metabolite-inspired compounds show promise for ulcerative colitis drug discovery
监管与产业动态评分2424 Hatteras banks on portfolio with upsized Opportunity Fund
监管与产业动态精选评分3434 Tracing fetal DNA through maternal blood can help reduce prenatal testing errors
监管与产业动态评分2323 Teva, Samsung Bioepis deepen bonds in pact for up to 6 new biosimilars - Fierce Pharma
监管与产业动态评分1010 Locking in on pharma’s consumerization trend - Fierce Pharma
监管与产业动态评分2020 ‘We’ve been taking our time’: Buzzy AI biotech Xaira reveals antibody platform, first taste of pipeline - Fierce Biotech
监管与产业动态精选评分5050 New weight-loss injection targets fat cells: CBL-514 selectively induces apoptosis of fat cells
监管与产业动态评分1818 Pfizer touts 'dermatology momentum' as it paints fuller picture of Litfulo's vitiligo potential - Fierce Pharma
监管与产业动态评分2727 Pharma partnering in China gets earlier and broader
监管与产业动态评分1010 For biopharma manufacturing at speed and scale, the future is flexible - Fierce Pharma
监管与产业动态评分2727 Small GLOBE, big precedent: a Perspective
监管与产业动态精选评分3838 Circle’s $92.5M round puts cyclin D1 program ahead of clinical lead
监管与产业动态评分6767 Novartis turns to mRNA-encoded engagers for B cell depletion